245th ACS National Meeting and Exposition

280 – Discovery and development of MGL-3196, a liver-directed thyroid hormone beta agonist for the treatment of hypercholesterolemia/dyslipidemia and hypertriglyceridemia
April 10, 2013, 4:20pm | First Time Disclosures Session, Morial Convention Center, Room R02-R04 | New Orleans, Louisiana